Prevalence of Resistant Gram-Negative Bacilli in Bloodstream Infection in Febrile Neutropenia Patients Undergoing Hematopoietic Stem Cell Transplantation

Medicine (United States)

Volumn 94, Issue 45, 2015, Pages e1931-

  Wang, Ling ^a   Wang, Ying ^a   Fan, Xing ^a   Tang, Wei ^a   Hu, Jiong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM;

ACINETOBACTER BAUMANNII; ACINETOBACTER LWOFFII; ADOLESCENT; ADULT; AEROCOCCUS; ARCANOBACTERIUM; ARCANOBACTERIUM HAEMOLYTICUM; ARTICLE; BLOODSTREAM INFECTION; BURKHOLDERIA CEPACIA; CANDIDA TROPICALIS; CAUSE OF DEATH; CHRYSEOBACTERIUM INDOLOGENES; CITROBACTER FREUNDII; CONTROLLED STUDY; EDWARDSIELLA TARDA; ELIZABETHKINGIA MENINGOSEPTICA; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; ESCHERICHIA COLI; FEBRILE NEUTROPENIA; FEMALE; FUNGUS; GEMELLA MORBILLORUM; GRAM NEGATIVE INFECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFECTION RISK; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANCE; OVERALL SURVIVAL; PREVALENCE; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS STUTZERI; RETROSPECTIVE STUDY; RISK FACTOR; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS HOMINIS; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS MITIS; STREPTOCOCCUS SALIVARIUS; ANTIBIOTIC RESISTANCE; BACTEREMIA; COMPLICATION; GRAM NEGATIVE BACTERIUM; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; OUTCOME ASSESSMENT; YOUNG ADULT;

ADOLESCENT; ADULT; BACTEREMIA; DRUG RESISTANCE, BACTERIAL; FEBRILE NEUTROPENIA; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84958155803     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001931     Document Type: Article

References (33)

1. Ruhnke M, Arnold R, Gastmeier P. Infection control issues in patients with haematological malignancies in the era of multidrugresistant bacteria. Lancet Oncol. 2014;15:e606-e619.
2. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52:427-431.
3. Wisplinghoff H, Seifert H, Wenzel RP, et al. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis. 2003;36:1103-1110.
4. Klastersky J, Ameye L, Maertens J, et al. Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents. 2007;30(Suppl 1):S51-S59.
5. Gudiol C, Bodro M, Simonetti A, et al. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients. Clin Microbiol Infect. 2013;19:474-479.
6. Tacconelli E, Cataldo MA, Dancer SJ, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014;20(Suppl 1):1-55.
7. Hu FP, Zhu DM, Wang F, et al. CHINET 2013 surveillance of bacterial resistance in China. Chin J Infect Chemother. 2014;14:369-378.
8. Cappellano P, Viscoli C, Bruzzi P, et al. Epidemiology and risk factors for bloodstream infections after allogeneic hematopoietic stem cell transplantation. New Microbiol. 2007;30:89-99.
9. Frère P, Hermanne JP, Debouge MH, et al. Bacteremia after hematopoietic stem cell transplantation: incidence and predictive value of surveillance cultures. Bone Marrow Transplant. 2004;33:745-749.
10. Chen X, Wang WK, Han LZ, et al. Epidemiological and genetic diversity of Staphylococcus aureus causing bloodstream infection in Shanghai. PLoS ONE. 2013;8:e72811.
11. Franklin RC, Matthew AW, Jeff A, et al. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. CLSI Document M100-S22. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.
12. Averbuch D, Cordonnier C, Livermore DM, et al. Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011). Haematologica. 2013;98:1836-1847.
13. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268-281.
14. Almyroudis NG, Fuller A, Jakubowski A, et al. Pre-and postengraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2005;7:11-17.
15. Poutsiaka DD, Price LL, Ucuzian A, et al. Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality. Bone Marrow Transplant. 2007;40:63-70.
16. Mikulska M, Del Bono V, Raiola AM, et al. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance. Biol Blood Marrow Transplant. 2009;15:47-53.
17. Chen CY, Tsay W, Tang JL, et al. Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia. Epidemiol Infect. 2010;138:1044-1051.
18. Mikulska M, Del Bono V, Bruzzi P, et al. Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients. Infection. 2012;40:271-278.
19. Busca A, Cavecchia I, Locatelli F, et al. Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxis. Transpl Infect Dis. 2012;14:40-48.
20. Blennow O, Ljungman P, Sparrelid E, et al. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations. Transpl Infect Dis. 2014;16:106-114.
21. Castagnola E, Bagnasco F, Faraci M, et al. Incidence of bacteremias and invasive mycoses in children undergoing allogeneic hematopoietic stem cell transplantation: a single center experience. Bone Marrow Transplant. 2008;41:339-347.
22. Oliveira AL, de Souza M, Carvalho-Dias VM, et al. Epidemiology of bacteremia and factors associated with multi-drug-resistant gramnegative bacteremia in hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2007;39:775-781.
23. Han TT, Huang XJ, Liu KY, et al. Blood stream infections during agranulocytosis period after hematopoietic stem cell transplantation in one single center. Zhonghua Nei Ke Za Zhi. 2011;50:654-658.
24. Liu CY, Lai YC, Huang LJ, et al. Impact of bloodstream infections on outcome and the influence of prophylactic oral antibiotic regimens in allogeneic hematopoietic SCT recipients. Bone Marrow Transplant. 2011;46:1231-1239.
25. El-Mahallawy H, Samir I, Abdel Fattah R, et al. Source, pattern and antibiotic resistance of blood stream infections in hematopoietic stem cell transplant recipients. J Egypt Natl Cancer Inst. 2014;26:73-77.
26. Wang F, Zhu DM, Hu FP, et al. 2012 CHINET surveillance of bacterial resistance in China. Chin J Infect Chemother. 2013;13:321-330.
27. Cattaneo C, Quaresmini G, Casari S, et al. Recent changes in bacterial epidemiology and the emergence of fluoroquinoloneresistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution. J Antimicrob Chemother. 2008;61:721-728.
28. Trecarichi EM, Tumbarello M, Caira M, et al. Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies. Haematologica. 2011;96:e1-e3.
29. Katsios CM, Burry L, Nelson S, et al. An antimicrobial stewardship program improves antimicrobial treatment by culture site and the quality of antimicrobial prescribing in critically ill patients. Crit Care. 2012;16:R216.
30. Gupta N, Limbago BM, Patel JB, et al. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis. 2011;53:60-67.
31. Perez F, Van Duin D. Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients. Cleve Clin J Med. 2013;80:225-233.
32. Scott BL, Park JY, Deeg HJ, et al. Pretransplant neutropenia is associated with poor-risk cytogenetic features and increased infection-related mortality in patients with myelodysplastic syndromes. Biol Blood Marrow Transplant. 2008;14:799-806.
33. Gyssens IC, Kern WV, Livermore DM. ECIL-4, a joint venture of EBMT, EORTC, ICHS and ESGICH of ESCMID. The role of antibiotic stewardship in limiting antibacterial resistance among hematology patients. Haematologica. 2013;98:1821-1825.